M. Andrieu et al., Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation, EUR J IMMUN, 30(11), 2000, pp. 3256-3265
CD8(+) T lymphocytes, which are major immune effecters, require primary sti
mulation by dendritic cells (DC) presenting MHC class I molecule-bound epit
opes. Sensitization to exogenous protein epitopes that are not synthesized
in DC, such as cross-priming, is obtained through pathways leading to their
association with MHC class I. To follow class I-restricted pathways in hum
an DC, we have tracked a lipopeptide derived from the conserved HLA-A*0201-
restricted HIV-1 reverse transcriptase 476-484 epitope, by N-terminal addit
ion of an N epsilon -palmytoyl-lysine. Indeed, lipopeptides elicit cytotoxi
c responses from CD8(+) T lymphocytes, whereas peptides without a lipid moi
ety do not. The lipopeptide and its parent peptide were labeled unequivocal
ly by rhodamine to study their entry into immature monocyte-derived human D
C by confocal microscopy. The lipid moiety induced endocytosis of the lipop
eptide, assessed by rapid entry into vesicles, colocalization with Dextran-
FITC and dependence on energy. Internalization occurred even when actin fil
aments were depolymerized by Cytochalasin B. This internalization induced f
unctional stimulation of specific CD8(+) T lymphocytes in IFN-gamma ELISPOT
assays. The peptide alone was not visualized inside the DC and was present
ed through direct surface association to HLA-A*0201. Therefore, lipopeptide
s are a unique opportunity to define precisely the pathways that lead exoge
nous proteins to associate with MHC class I molecules in DC. The results wi
ll also be useful to design lipopeptide vaccines.